🇺🇸 FDA
Pipeline program

Naltrexone HCl/Bupropion HCl Placebo

NaltrexBuprop-4004

Approved small_molecule terminated

Quick answer

Naltrexone HCl/Bupropion HCl Placebo for Weight Regain Post Bariatric Surgery is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Weight Regain Post Bariatric Surgery
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials